BP5-71912-51664
5 vaccinations
10 coded responses
58 check-ins
10 free-text entries
4 call cases
- Sex
- —
- Age at first dose
- 26-30
- ZIP prefix
- 191 / PA
- Registered
- 2021-02-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-22
Registered in v-safe
-
2021-02-22
Dose 1 — Moderna
- 2021-02-22
-
2021-02-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache · Be unable to workAdult check-in
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
-
2021-03-08
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash — Feeling: FairFree text: Soreness and itchy red rash at injection site one week after vaccine, lasting 48 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-17
-
2021-03-22
Dose 2 — Moderna
-
2021-03-22
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-03-23
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Diarrhea · Be unable to workAdult check-in
-
2021-03-25
Survey response — days 1–6 daily, dose 2MedDRA: Anxiety, Panic attack — Feeling: Poor · Site: Pain, Swelling, Itching · Headache, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesFree text: Increased anxiety/feelings of panic attacksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
-
2021-05-03
Survey response — day 42, dose 2MedDRA: Irritable bowel syndrome, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Flare of IBS symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-21
-
2021-09-20
Survey response — 6 months, dose 2MedDRA: Deafness unilateral, Haemorrhoids thrombosed, Tenosynovitis stenosans — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: De Quervain's tenosynovitis, thrombosed hemorrhoid, minor loss of hearing in left ear likely due to clogMedDRA releases: 2024-11 · check-in free text available
-
2021-10-23
Dose 3 — Moderna
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-30
Health check-in — day 7, dose 3Feeling: Fair · Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-06
Survey response — day 14, dose 3MedDRA: Nausea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Ongoing nauseaMedDRA releases: 2024-11 · check-in free text available
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-06
- 2022-01-22
- 2022-03-08
- 2022-03-08
- 2022-04-23
-
2022-08-09
Dose 4 — Pfizer-BioNTech
-
2022-08-10
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-08-11
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-08-12
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-08-13
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-08-14
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2022-08-15
Survey response — days 1–6 daily, dose 4MedDRA: Panic attack — Feeling: Poor · Be unable to work or attend schoolFree text: Severe panic attacksMedDRA releases: 2024-11 · check-in free text available
- 2022-08-16
-
2022-08-30
Survey response — day 21, dose 4MedDRA: Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Migraine lasting 6 daysMedDRA releases: 2024-11 · check-in free text available
-
2022-08-30
Report sent to call center — day 21, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-31
- 2022-08-31
- 2022-08-31
- 2022-09-06
-
2022-09-20
Survey response — day 42, dose 4MedDRA: Bartholin's cyst, Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Bartholin's cyst, intensified migrainesMedDRA releases: 2024-11 · check-in free text available
-
2022-09-20
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-21
- 2022-09-21
- 2022-09-21
- 2022-09-21
-
2022-10-21
Dose 5 — Pfizer-BioNTech
-
2022-10-22
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-10-23
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-25
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2022-10-26
-
2022-10-27
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-10-28
- 2022-11-04
-
2022-11-11
Survey response — day 21, dose 5MedDRA: Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: VomitingMedDRA releases: 2024-11 · check-in free text available
- 2022-11-20
-
2022-11-25
Survey response — day 35, dose 5MedDRA: Blood pressure increased, Heart rate increased — Feeling: GoodFree text: Rapid heart rate and increased blood pressureMedDRA releases: 2024-11 · check-in free text available
- 2022-12-02
- 2023-01-20
- 2023-04-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-22 | Moderna | |
| 2 | 2021-03-22 | Moderna | |
| 3 | 2021-10-23 | Moderna | No |
| 4 | 2022-08-09 | Pfizer-BioNTech | No |
| 5 | 2022-10-21 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 unsuccessful
2 waits over 3 months for a first call
Free text
Release 5 — day 14, dose 1
Symptoms: Soreness and itchy red rash at injection site one week after vaccine, lasting 48 hours
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Increased anxiety/feelings of panic attacks
Release 8 — day 42, dose 2
Symptoms: Flare of IBS symptoms
Release 9 — 6 months, dose 2
Symptoms: De Quervain's tenosynovitis, thrombosed hemorrhoid, minor loss of hearing in left ear likely due to clog
Release 10 — day 14, dose 3
Symptoms: Ongoing nausea
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Severe panic attacks
Release 12 — day 21, dose 4
Symptoms: Migraine lasting 6 days
Release 12 — day 42, dose 4
Symptoms: Bartholin's cyst, intensified migraines
Release 12 — day 21, dose 5
Symptoms: Vomiting
Release 12 — day 35, dose 5
Symptoms: Rapid heart rate and increased blood pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bartholin's cyst | · | · | ✓ |
| SD | Blood pressure increased | · | · | ✓ |
| SD | Deafness unilateral | · | · | ✓ |
| SD | Haemorrhoids thrombosed | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Irritable bowel syndrome | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Tenosynovitis stenosans | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Anxiety | ✓ | ✓ | ✓ |
| SRO | Panic attack | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release